Please provide your email address to receive an email when new articles are posted on . Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers ...
Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca ...
Dr. J. Nicholas Bodor of Fox Chase Cancer Center explains possible risk factors, symptoms to watch for, and the importance of ...
Campaign aims to improve lung cancer survival through early detection, education and widespread access to biomarker testing. CHICAGO, Aug. 20, 2025 /PRNewswire/ -- For people with lung cancer, ...
Chronic cough, breathlessness or pollution exposure may signal underlying lung disease. Here's when you should consider a ...
Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of actionable mutations. Biomarker testing for patients with lung cancer is critical, ...
"Our study shows that reaching patients directly with digital tools can help overcome barriers to lung cancer screening and ...
Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch of a new method of ...
Disparities in lung cancer biomarker testing show barriers that delay diagnosis and treatment for lower-income patients, according to Sandip P. Patel, MD. Patients with lower socioeconomic status were ...
Some 77% of patients saw their tumours shrink, 8% saw them completely disappear, and 69% saw partial shrinkage of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results